vh2021
  • Home
  • About
    • Committee
    • Environmental Policy
    • Privacy Policy
  • Registration
    • Why register
    • Terms & Conditions
  • Keynote Speakers
  • Abstract Submission
  • Sponsorship & Exhibition
    • Sponsors
    • Why Sponsor
    • Digital Toolkit
  • Contact Us
  • Search
  • Menu Menu
  • Twitter
  • Facebook

VH2021

ABOUT

Join Our Mailing List

KEY DEADLINES



Abstract Submission Deadline: CLOSED


Early Bird Registration Deadline: 28 March 2021


Accommodation Deadline: 25 April 2021


Standard Registration Deadline: 16 May 2021

REGISTER

The Australasian Viral Hepatitis Conference is run by ASHM in collaboration with key sector partners as a platform for the dissemination and presentation of new and innovative research findings and better management across the Australasian viral hepatitis sector. Through this forum we aim to support the health workforce, government and community to work towards the elimination of hepatitis B and hepatitis C and supporting the communities living with these conditions in Australia, New Zealand and the Asia and Pacific regions.

The objectives of the conference are to:

  1. Provide a forum for the workforce to keep up to date with research, clinical management, prevention, best practice and policy, including professional development and activities for relevant accreditation.
  2. Develop a program that appeals to the multidisciplinary audience working in or interested in viral hepatitis and reflects the changing environment for the care and management of viral hepatitis.
  3. Facilitate dialogue between researchers, community, government and clinicians across different geographic locations inside Australasia and from the region.
  4. Encourage the participation of:
    a. people living with or affected by, hepatitis B and/or hepatitis C
    b. new and early career clinicians, researchers, allied health and community members
    c. international leaders in the sector through grants and scholarships
    d. additional attendees through a scholarship program
    e. researchers and scientists working in the development of new viral hepatitis therapies, investigations and other technical applications
  5. Disseminate knowledge and applied learning during and after the conference for wider audience education
  6. Recognise and build sector leadership through awards and invited presentations
  7. Provide a local forum for the sector to gain professional development skills
  8. Ensure the conference delivers a budget surplus to support future initiatives

For information on past Australasian Viral Hepatitis Conferences, including programs, presentations and handbooks, please visit www.ashm.org.au

HISTORY

2018 ADELAIDE

503 DELEGATES


2016 GOLD COAST

444 DELEGATES


2014 ALICE SPRINGS

406 DELEGATES


2012 AUCKLAND

613 DELEGATES


2010 MELBOURNE

606 DELEGATES


2008 BRISBANE

468 DELEGATES


2006 SYDNEY

346 DELEGATES


2004 CANBERRA

284 DELEGATES

Copyright 2020 by ASHM Conference & Events Division
Scroll to top